Clinical trial • Not applicable • Neurology
Clinical trial in Idiopathic intracranial hypertension
Not applicable trial for Idiopathic intracranial hypertension. 96 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Idiopathic intracranial hypertension
- Trial Stage
- Not applicable
Key dates
- Initial CTIS Submission Date
- 10-12-2025
- First CTIS Authorization Date
- 13-04-2026
Trial design
Not applicable trial across 2 sites in Denmark.
- Target Sample Size
- 96
- Trial Duration For Participant
- 1095
Eligibility
Recruits 96 No vulnerable populations selected (isVulnerablePopulationSelected=false); consent/assent handling not specified..
- Vulnerable Population
- No vulnerable populations selected (isVulnerablePopulationSelected=false); consent/assent handling not specified.
Recruitment
- Planned Sample Size
- 96
- Recruitment Window Months
- 36
Geography
- Total Number Of Sites
- 2
- Total Number Of Participants
- 96
Denmark
- Earliest CTIS Part Ii Submission Date
- 07-04-2026
- Latest Decision Or Authorization Date
- 13-04-2026
- Processing Time Days
- 6
- Number Of Sites
- 2
- Number Of Participants
- 96
Sites
- Site Name
- Odense University Hospital
- Department Name
- Dept. of neurology
- Contact Person Name
- Dagmar Beier
- Contact Person Email
- Dagmar.Beier@rsyd.dk
- Site Name
- Rigshospitalet
- Department Name
- Dept. of neurology
- Contact Person Name
- Rigmor Jensen
- Contact Person Email
- rigmor.jensen@regionh.dk
Sponsor
Primary sponsor
- Full Name
- Rigshospitalet
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Denmark
Related trials
Other published trials that may interest you.
- OCRELIZUMAB for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Secondary progressive multiple sclerosis (active)
- CENOBAMATE for Partial-onset (focal) seizures
- Ocrelizumab for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Active secondary progressive multiple sclerosis
- Clinical trial in Parkinson's disease
- Tenecteplase for Acute ischaemic stroke due to basilar artery occlusion | Posterior circulation ischaemic stroke